Jounce Therapeutics Garners $47,000,000 Series A Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fbbaf292-bb6c-428e-84b3-458028c07fd7&Preview=1 -
Date
2/14/2013 -
Company Name
Jounce Therapeutics -
Mailing Address
1030 Massachusetts Avenue Cambridge, MA 02138 -
Company Description
Jounce Therapeutics is focused on the discovery and development of first-in-class cancer immunotherapies designed to work not by treating a patient’s tumor directly, but instead by harnessing the patient’s immune system to seek out and attack cancerous cells and tumors. -
Website
http://www.jouncetx.com -
Transaction Type
Venture Equity -
Transaction Amount
$47,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Third Rock Ventures
